Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

Scan the FCA Value Measures and you’ll see a consistent pattern: Home Legal Expenses products with complaints ratios above 10%, low claims acceptance rates and low claims frequencies.
The natural question is: Why?
And more importantly: Which levers can insurers actually pull to fix it?
Complaints in Home Legal aren’t random. If you work through the Financial Ombudsman’s published data or look at the excellent review the Legal Services Board undertook (link here) you find consistent themes.
Common issues include:
So what is noise and what is signal? And importantly how do turn this into actionable insight? This is where root cause analysis becomes your most powerful tool.
Root cause analysis forces you to ask:
Fixing this is not about tweaking SLAs or rewriting a few definitions in a policy wording.
It’s about understanding where customer’s expectation and their actual outcomes become mis-aligned.
Why this happens and crucially what actions can be taken to improve it.
Root cause analysis is where transformation begins, because it reveals the truth behind the symptoms.
About Elevate Specialty
Elevate Specialty is a next-generation, full-stack MGA making insurance work—by design. Using technology, granular data, and relentless customer focus, Elevate creates native insurance products that people actually use and value.
We are rebuilding legal expenses, cyber, income protection and other underserved insurance classes from the ground up. Our model uses continuous improvement cycles, customer‑journey data, and rapid operational change to fix problems at the root. We deliver higher engagement, better outcomes, and lower costs by design.
More at: elevatespecialty.com
Copyright © 2026 Elevate Specialty Limited registered in England and Wales, Company Number 15651787. All Rights Reserved.
Elevate Specialty Limited (FRN1022230) is an appointed representative of Advent Solutions Management Limited. Advent Solutions Management Limited is authorised and regulated by the Financial Conduct Authority (FRN 308751).